MiRNA profile associated with replicative senescence, extended cell culture, and ectopic telomerase expression in human foreskin fibroblasts.
Senescence is a highly regulated process that limits cellular replication by enforcing a G1 arrest in response to various stimuli. Replicative senescence occurs in response to telomeric DNA erosion, and telomerase expression can offset replicative senescence leading to immortalization of many human cells. Limited data exists regarding changes of microRNA (miRNA) expression during senescence in human cells and no reports correlate telomerase expression with regulation of senescence-related miRNAs. We used miRNA microarrays to provide a detailed account of miRNA profiles for early passage and senescent human foreskin (BJ) fibroblasts as well as early and late passage immortalized fibroblasts (BJ-hTERT) that stably express the human telomerase reverse transcriptase subunit hTERT. Selected miRNAs that were differentially expressed in senescence were assayed for expression in quiescent cells to identify miRNAs that are specifically associated with senescence-associated growth arrest. From this group of senescence-associated miRNAs, we confirmed the ability of miR-143 to induce growth arrest after ectopic expression in young fibroblasts. Remarkably, miR-143 failed to induce growth arrest in BJ-hTERT cells. Importantly, the comparison of late passage immortalized fibroblasts to senescent wild type fibroblasts reveals that miR-146a, a miRNA with a validated role in regulating the senescence associated secretory pathway, is also regulated during extended cell culture independently of senescence. The discovery that miRNA expression is impacted by expression of ectopic hTERT as well as extended passaging in immortalized fibroblasts contributes to a comprehensive understanding of the connections between telomerase expression, senescence and processes of cellular aging.
Bonifacio
Laura N
LN
Division of Medicinal Chemistry and Natural Products, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Jarstfer
Michael B
MB
D002453:Cell Cycle; D002460:Cell Line; D002478:Cells, Cultured; D016922:Cellular Senescence; D005347:Fibroblasts / Q000166:cytology* / Q000201:enzymology / Q000378:metabolism; D052816:Foreskin / Q000166:cytology* / Q000201:enzymology / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D019098:Telomerase / Q000235:genetics* / Q000378:metabolism
D035683:MicroRNAs; D019098:Telomerase
Cancer Res. 2007 Dec 1;67(23):11099-101
18056431
Nature. 2009 Jul 2;460(7251):66-72
19571879
Nat Biotechnol. 2010 Apr;28(4):341-7
20351690
J Cell Physiol. 2009 Oct;221(1):109-19
19475566
Biochim Biophys Acta. 2009 Jun;1792(6):497-505
19268705
Cell Death Differ. 2010 Feb;17(2):236-45
19696787
Nucleic Acids Res. 2008 Sep;36(16):5391-404
18701644
EMBO J. 2003 Aug 15;22(16):4212-22
12912919
Curr Atheroscler Rep. 2009 May;11(3):236-42
19361356
Genome Res. 2010 Apr;20(4):440-6
20219944
Oncogene. 2008 Oct 9;27(46):5975-87
18711403
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14723-8
9843956
Oncol Rep. 2006 Oct;16(4):845-50
16969504
Cancer Gene Ther. 2010 Jun;17(6):398-408
20094072
Nature. 2008 Aug 7;454(7205):766-70
18600261
Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E110-6
20424141
PLoS One. 2009 Jun 09;4(6):e5848
19513126
PLoS One. 2010 May 20;5(5):e10724
20505758
Biochim Biophys Acta. 2009 Apr;1792(4):341-52
19419692
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15472-7
17875987
Aging (Albany NY). 2009 Apr;1(4):402-11
20148189
Nat Rev Cancer. 2002 Aug;2(8):627-33
12154355
Mol Cell Biol. 2005 Sep;25(18):8037-43
16135795
Genome Res. 2010 Apr;20(4):434-9
20219945
J Biol Chem. 2008 Feb 1;283(5):2654-62
18048365
Nat Cell Biol. 2009 Sep;11(9):1135-42
19701195
Nature. 2007 Jun 28;447(7148):1130-4
17554337
Nat Protoc. 2006;1(3):1112-6
17406391
Nature. 2007 Feb 8;445(7128):656-60
17251933
J Biol Chem. 2010 Mar 12;285(11):7986-94
20075075
Mol Syst Biol. 2008;4:229
19034270
Int J Oncol. 2002 Jun;20(6):1247-53
12012006
Leukemia. 2010 Feb;24(2):460-6
19956200
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7024-9
16641092
Nature. 2010 Mar 18;464(7287):374-9
20237562
Mol Cell Biol. 2000 Jan;20(1):273-85
10594030
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2976-85
20053980